eXalt3: Phase III randomized study comparing ensartinib to crizotinib in anaplastic lymphoma kinase positive non-small cell lung cancer patients
2018 ◽
Vol 29
◽
pp. viii543
L. Horn
◽
Y.-L. Wu
◽
M. Reck
◽
H. Wakelee
◽
C. Liang
◽
...
2018 ◽
Vol 13
(10)
◽
pp. S582
◽
L. Horn
◽
Y. Wu
◽
M. Reck
◽
H. Wakelee
◽
C. Liang
◽
...
2018 ◽
Vol 33
(4)
◽
pp. 549-550
Giulio Metro
◽
Diana Giannarelli
◽
Angelo Sidoni
◽
Rita Chiari
◽
Guido Bellezza
Ha Yeon Lee
◽
Hee Kyung Ahn
◽
Ji Yun Jeong
◽
Mi Jung Kwon
◽
Jung-Ho Han
◽
...
2012 ◽
Vol 77
(2)
◽
pp. 288-292
◽
Heae Surng Park
◽
June Koo Lee
◽
Dong-Wan Kim
◽
Kimary Kulig
◽
Tae Min Kim
◽
...
2013 ◽
Vol 14
(5)
◽
pp. 597-608
◽
Sara Pilotto
◽
Umberto Peretti
◽
Silvia Novello
◽
Giulio Rossi
◽
Michele Milella
◽
...
2019 ◽
Vol 14
(10)
◽
pp. S566
H. Wakelee
◽
K. Reckamp
◽
T. Leal
◽
A. Chiappori
◽
S. Waqar
◽
...
Stefanie L. Groenland
◽
Dieuwertje R. Geel
◽
Julie M. Janssen
◽
Niels Vries
◽
Hilde Rosing
◽
...
2019 ◽
Vol 14
(10)
◽
pp. S911
C. Choi
◽
Y.J. Kim
◽
J.C. Lee
◽
S. Kim
◽
D.H. Lee
◽
...
2018 ◽
Vol 10
(1)
◽
pp. 106-108
◽
Cesare Gridelli
◽
Francesca Casaluce
◽
Assunta Sgambato
◽
Giovanni Palazzolo
◽
Paolo Maione
2017 ◽
Vol Volume 11
◽
pp. 75-82
◽
Marco D DiBonaventura
◽
William Wong
◽
Bijal Shah-Manek
◽
Mathias Schulz